5 articles
The 'Indica' versus 'Sativa' binary is an antiquated classification system that fails to predict actual physiological outcomes. Botanical morphology—the shape of the leaf or the height of the plant—does not dictate psychotropic effects. True sedation is a byproduct of specific chemical interactions between cannabinoids and terpene alcohols or hydrocarbons. While Myrcene and Linalool are both primary drivers of the sedative entourage effect, they operate through distinct biological pathways.
The era of 'THC-is-King' in cannabis retail is hitting a wall. For years, the market relied on a simple, flawed metric: if the percentage was higher, the product was better. Consumers are becoming more sophisticated, and the data is catching up. We are seeing a pivot away from pure potency toward terpene profiles and minor cannabinoids—a shift rooted in the pharmacological reality of the entourage effect.
For years, the cannabis industry focused almost exclusively on THC percentages. If you have ever wondered why two strains with identical THC levels produce different experiences, the answer is found in the chemistry of the whole plant.
The cannabis industry is outgrowing the 'THC arms race.' For years, shelf space was dominated by the highest percentages, but a shift toward secondary metabolite complexity is underway. The 'entourage effect'—the pharmacological interaction between 100+ cannabinoids and 150+ terpenes—has moved from a marketing buzzword to the bedrock of product strategy. In this market, pure THC isolates are becoming a low-value commodity, while full-spectrum formulations serve as the standard for premium extracts.
For years, the cannabis industry operated under a 'THC-is-King' fallacy. This was a byproduct of an immature market—a legacy of prohibition-era scarcity where potency was the primary metric used to judge quality.